http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022042997-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6c6f4df9d92b667762a8445c73d4892
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca869368cd0021db3a30de2d26a76526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3710dd367b4ae93e2ec049372bf51fd6
publicationDate 2022-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022042997-A1
titleOfInvention Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
abstract The present invention relates to a method for the diagnosis or the prognosis of metastasis in prostate cancer which comprises determining if the c-MAF gene is amplified in a primary tumor sample. Likewise, the invention also relates to a method for the diagnosis or the prognosis of metastasis in prostate cancer, as well as to a method for determining the tendency to develop bone metastasis with respect to metastasis in other organs, which, comprise determining the c-MAF expression level. Finally, the invention relates to the use of a c-MAF inhibitor as therapeutic target for treating the prostate cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596642-B2
priorityDate 2012-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466385259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158808215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457965171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163904548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163850316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449799239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466415780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458043075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457952892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465572648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465651619

Total number of triples: 47.